The Stem Cell Therapeutic Outcomes Database (SCTOD) is one of four components of the C.W. Bill Young Cell Transplantation Program (Program). According to the SCTOD contract, this contractor will:
To learn about the organization holding the SCTOD contract, see Center for International Blood and Marrow Transplant Research, a Program Contractor.
Learn about the organization holding this contract.
Learn how the Program helps more patients have a successful bone marrow or umbilical cord blood transplant. The Program is authorized by the Stem Cell Therapeutic and Research Act of 2005, Public Law 109-129 and the Stem Cell Therapeutic and Research Reauthorization Act of 2010, Public Law 111-264.
A bone marrow or cord blood transplant (also called a BMT) replaces a patient's diseased cells with healthy blood-forming cells so that the patient can live a longer, healthier life. The blood-forming cells (stem cells) used for transplant can come from the patient (autologous) or from a relative or unrelated donor (allogeneic). Learn about:
The SCTOD stores data about marrow and cord blood transplants and provides information for research to improve patient outcomes.